Analysis of The Market Trend

The market as a whole remains relatively stable, with little fluctuation, and domestic and international markets remain cautious, focusing on rigid demand.

Domestic downstream customers selectively make some off-season reserves for some products; Some manufacturers have stopped production for maintenance,  With lower operating rate, lower inventory, to ensure the price can be stable, rebounded, even goes up.

With the arrival of the stock cycle, as well as the uncertainty of the second outbreak of COVID-19 secondary epidemic, signs of market recovery slowly emerged;

Among herbicides,

the rising products include Glufosinate ammonium, metolachlor, quinclorac, etc.; the falling ones include atrazine, clethodim, haloxyfop-p-methyl, etc.;

Sulfonylurea herbicide are shortage in supplying (Limited by raw materials)like : Metsulfuron , tribenuron-methyl

Among insecticides,

the rising products include spirodiclofen, bifenazate, imidacloprid, thiamethoxam, acetamiprid, etc.,

the falling ones include lambda cyhalothrin, emamectin benzoate, lufenuron, abemectin, etc.;

Among fungicides,

the rising products include tebuconazole, thiophanate methyl, etc.,

the falling ones include azoxystrobin ,pyraclostrobin, epoxiconazole, chlorothalonil and so on.

1. Glyphosate

Fuhua and Hebang announced that they will resume production,  although the inventory is small, they don’t have sales pressure in short time, because they need to complete pre-orders, moreover, the material of yellow phosphorus and glycine have rised, the price from factories become relatively stable, even the price from traders are loosening.

2. Glufosinate ammonium

 The supply is still tight. The potential production capacity previously announced to enter the market has not been released as scheduled. The market supply pattern has not changed much. The mainstream suppliers have sufficient orders and the sales pressure is not large. The yellow phosphorus price rises and the season arrives, the manufacturers still have their expectations of upward adjustments, but the market demand feedback is average, and most of them are on-demand purchases;

3. Clethodim

Stable and big supply. Main demand is for foreign market, not big. The price is dropping.

4. Chlorpyrifos

 Supply is stable, but weak demand. The price was dropping . But the raw material is rising up on price. It has pressure to go up.

5. Thiamethoxam

The price of intermediate thiazole of it is increasing, the price is going up. Moreover, the previous price is near to production cost, in order to reduce loss,  some plants shut down, maintain equipment,  the supplying is limited. So It is time to place the order.

6. Imidacloprid,  Acetamiprid

In the pass several months, weak demand, high inventory, the price had dropped to cost line. Recently, DMF, one material of it, its price doubled, so the price is going up.

7. Emamectin benzoate

The supply of raw materials is sufficient. The situation of export is tough, the price is keeping dropping and becoming stable recently.

8. Lambda cyhalothrin

The demand is flat, inventory increases, the price is keeping decreasing, but the speed of decreasing has slowed.

9. Azoxystrobin

 Production situation is stable, the supply is stable, too. Big sales pressure is facing.

Expectation:  Weak demand, strong supply. The price is going down.

10. Difenoconazole

The operating rate of factories has increased, the supply becomes larger and stable, but the downstream demand is flat, it is expected the price will go down.

11. Tebuconazole

At present, main manufacturers have sufficient orders and no sales pressure. And the price rebounded along with the increasing price of its raw materials.

Expectation:  From the trend line, it is obvious that the factories are increasing the price slightly.

12. Prochloraz

The supply of material is sufficient, and more factories can produce it, so the price of it is decreasing.